Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD by Schlenk, Richard F., Weber, Daniela, Fiedler, Walter, Salih, Helmut R., Wulf, Gerald, Salwender, Hans, Schroeder, Thomas, Kindler, Thomas, Lübbert, Michael, Wolf, Dominik, Westermann, Jörg, Kraemer, Doris, Götze, Katharina S., Horst, Heinz-August, Krauter, Jürgen, Girschikofsky, Michael, Ringhoffer, Mark, Südhoff, Thomas, Held, Gerhard, Derigs, Hans-Günter, Schroers, Roland, Greil, Richard, Grießhammer, Martin, Lange, Elisabeth, Burchardt, Alexander, Martens, Uwe, Hertenstein, Bernd, Marretta, Lore, Heuser, Michael, Thol, Felicitas, Gaidzik, Verena I., Herr, Wolfgang, Krzykalla, Julia, Benner, Axel, Döhner, Konstanze, Ganser, Arnold, Paschka, Peter, Döhner, Hartmut

Get full text

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) by Gaidzik, Verena I., Schlenk, Richard F., Paschka, Peter, Stölzle, Anja, Späth, Daniela, Kuendgen, Andrea, von Lilienfeld-Toal, Marie, Brugger, Wolfram, Derigs, Hans Günter, Kremers, Stephan, Greil, Richard, Raghavachar, Aruna, Ringhoffer, Mark, Salih, Helmut R., Wattad, Mohammed, Kirchen, Heinz G., Runde, Volker, Heil, Gerhard, Petzer, Andreas L., Girschikofsky, Michael, Heuser, Michael, Kayser, Sabine, Goehring, Gudrun, Teleanu, Maria-Veronica, Schlegelberger, Brigitte, Ganser, Arnold, Krauter, Jürgen, Bullinger, Lars, Döhner, Hartmut, Döhner, Konstanze

Get full text

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, mult... by Ravandi, Farhad, Prof, Ritchie, Ellen K, MD, Sayar, Hamid, MD, Lancet, Jeffrey E, MD, Craig, Michael D, MD, Vey, Norbert, Prof, Strickland, Stephen A, MD, Schiller, Gary J, Prof, Jabbour, Elias, MD, Erba, Harry P, Prof, Pigneux, Arnaud, Prof, Horst, Heinz-August, Prof, Recher, Christian, Prof, Klimek, Virginia M, MD, Cortes, Jorge, Prof, Roboz, Gail J, MD, Odenike, Olatoyosi, MD, Thomas, Xavier, MD, Havelange, Violaine, MD, Maertens, Johan, Prof, Derigs, Hans-Günter, Prof, Heuser, Michael, MD, Damon, Lloyd, Prof, Powell, Bayard L, Prof, Gaidano, Gianluca, Prof, Carella, Angelo-Michele, MD, Wei, Andrew, MBBS, Hogge, Donna, Prof, Craig, Adam R, MD, Fox, Judith A, PhD, Ward, Renee, MD, Smith, Jennifer A, PhD, Acton, Gary, MD, Mehta, Cyrus, Prof, Stuart, Robert K, MD, Kantarjian, Hagop M, Prof

Get full text

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients by Tassara, Michela, Döhner, Konstanze, Brossart, Peter, Held, Gerhard, Götze, Katharina, Horst, Heinz-A., Ringhoffer, Mark, Köhne, Claus-Henning, Kremers, Stephan, Raghavachar, Aruna, Wulf, Gerald, Kirchen, Heinz, Nachbaur, David, Derigs, Hans Günter, Wattad, Mohammed, Koller, Elisabeth, Brugger, Wolfram, Matzdorff, Axel, Greil, Richard, Heil, Gerhard, Paschka, Peter, Gaidzik, Verena I., Göttlicher, Martin, Döhner, Hartmut, Schlenk, Richard F.

Get full text

Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study by Piringer, Gudrun, Thaler, Josef, Anchisi, Sandro, Geffriaud-Ricouard, Christine, Gueldner, Max, Scholten, Felicitas, Derigs, Hans-Günter, Bohanes, Pierre, Grünberger, Birgit, Schwarz, Leonora, von Moos, Roger, Hofheinz, Ralf-Dieter

Get full text

Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS) by Ronellenfitsch, Ulrich, Dimitrakopoulou-Strauss, Antonia, Jakob, Jens, Kasper, Bernd, Nowak, Kai, Pilz, Lothar R, Attenberger, Ulrike, Gaiser, Timo, Egerer, Gerlinde, Fröhling, Stefan, Derigs, Hans-Günter, Schwarzbach, Matthias, Hohenberger, Peter

Get full text

Azacitidine-Containing Induction Regimens Followed by Azacitidine Maintenance Therapy in High Risk Acute Myeloid Leukemia: First Results of the Randomized Phase-II AMLSG 12-09 Stud... by Schlenk, Richard F, Herr, Wolfgang, Wulf, Gerald, Salih, Helmut R, Krauter, Jürgen, Derigs, Hans Guenter, Kündgen, Andrea, Ringhoffer, Mark, Martens, Uwe M., Hertenstein, Bernd, Griesshammer, Martin, Girschikofsky, Michael, Bernhard, Helga, Kersten, Jens, von Lilienfeld-Toal, Maria, Koller, Elisabeth, Lange, Elisabeth, Westermann, Jörg, Späth, Daniela, Göhring, Gudrun, Teleanu, Veronica, Benner, Axel, Döhner, Konstanze, Ganser, Arnold, Döhner, Hartmut

Get full text

Bortezomib-Based Induction Therapy Followed by Autologous Stem Cell Transplantation and Maintenance Therapy with Bortezomib Improves Outcome In Myeloma Patients with Gain 1q21 and... by Goldschmidt, Hartmut, Neben, Kai, Bertsch, Uta, Hielscher, Thomas, van der Holt, Bronno, Hose, Dirk, Jarari, Laila el, Salwender, Hans, Blau, Igor Wolfgang, Pfreundschuh, Michael, Duehrsen, Ulrich, Weisel, Katja, Martin, Hans, Lindemann, Walter, Teschendorf, Christian, Haenel, Mathias, Scheid, Christof, van de Velde, Helgi, Derigs, Hans Guenter, Hoffmann, Martin, Peter, Norma, Kaufmann, Martin, Schmidt-Wolf, Ingo, Jauch, Anna, Lokhorst, Henk M, Sonneveld, Pieter

Get full text

Combining Information Regarding Chromosomal Aberrations t(4;14), Del(17p13) and the Copy Number of 1q21 with the International Staging System Classification Allows Stratification o... by Neben, Kai, Lokhorst, Henk M., Jauch, Anna, Bertsch, Uta, Hielscher, Thomas, Heiss, Christiane, van der Holt, Bronno, Schmitt, Stefan, Jarari, Laila el, Salwender, Hans J., Blau, Igor W., Pfreundschuh, Michael, Weisel, Katja, Duehrsen, Ulrich, Lindemann, Walter, Teschendorf, Christian, Martin, Hans, Scheid, Christof, Haenel, Mathias, Derigs, Hans Guenter, Graeven, Ullrich, Schmidt-Wolf, Ingo GH, Peter, Norma, Wattad, Mohammed, Luntz, Steffen P, Broyl, Annemiek, Schubert, Joerg, Hoffmann, Martin, Goerner, Martin, Tischler, Jochen, Kaufmann, Martin, Raab, Marc S, Ho, Anthony D., van de Velde, Helgi, Hose, Dirk, Sonneveld, Pieter, Goldschmidt, Hartmut

Get full text

Isocitrate Dehydrogenase Gene Mutations In Elderly Patients with Acute Myeloid Leukemia (AML) and Outcome After Treatment with All-Trans Retinoic Acid: A Study of the German-Austri... by Paschka, Peter, Schlenk, Richard F., Ibañez, Mariam, Kagias, Alexandra, Bullinger, Lars, Gaidzik, Verena I., Späth, Daniela, Horst, Heinz A., Held, Gerhard, Bentz, Martin, Kremers, Stephan, Greil, Richard, Wattad, Mohammed, Brugger, Wolfram, Runde, Volker, Raghavachar, Aruna, Derigs, Hans-Guenter, Kirchen, Heinrich, Döhner, Hartmut, Döhner, Konstanze

Get full text

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma by Hess, Georg, Flohr, Thomas, Kolbe, Karin, Bonn, Sarah, Schuler, Martin, Derigs, Hans Günter, Huber, Christoph

Get full text

Effector Function for RAS Oncogene in Interleukin-3-Dependent Myeloid Cells Involves Diminished Efficacy of Prostaglandin E1-Mediated Inhibition of Proliferation by Derigs, Hans Guenter, Klingberg, Debra, Tricot, Guido J., Boswell, H. Scott

Get full text

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre... by Kirschey, Sebastian, Flohr, Thomas, Wolf, Hans H., Frickhofen, Norbert, Gramatzki, Martin, Link, Hartmut, Basara, Nadezda, Peter, Norma, Meyer, Ralf G., Schmitz, Norbert, Weidmann, Eckhart, Banat, Andre, Schulz, Andrea, Kolbe, Karin, Derigs, Guenter, Theobald, Matthias, Hess, Georg

Get full text

Rituximab combined with Dexa BEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre... by Kirschey, Sebastian, Flohr, Thomas, Wolf, Hans H., Frickhofen, Norbert, Gramatzki, Martin, Link, Hartmut, Basara, Nadezda, Peter, Norma, Meyer, Ralf G., Schmitz, Norbert, Weidmann, Eckhart, Banat, Andre, Schulz, Andrea, Kolbe, Karin, Derigs, Guenter, Theobald, Matthias, Hess, Georg

Get full text